Valeur202020212022202320242025TTMFlux de trésorerie liés aux activités d'investissement-362 K-33.12 M-17.27 M-3.31 M-219.35 M68.58 M88.11 MFlux de trésorerie liés aux activités de financement37.49 M216.9 M-690 K187.07 M164.02 M173.65 M171.98 MFlux de trésorerie disponible-14.44 M-50.1 M-65 M1.88 M-126.23 M-243.39 M-271.54 M
EyePoint, Inc. - Common Stock
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.